Brief: Appili Therapeutics Announces Change To Board Of Directors
19/11/2021 12:47
Nov 19 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS ANNOUNCES POSITIVE ONE YEAR CHALLENGE
RESULTS FROM PRECLINICAL STUDY EVALUATING BIODEFENSE VACCINE
CANDIDATE ATI-1701 AND CHANGE TO BOARD OF DIRECTORS
* APPILI THERAPEUTICS INC - JOSEF VEJVODA HAS RESIGNED FROM
COMPANY'S BOARD OF DIRECTORS
* APPILI THERAPEUTICS - MAKING CONTINUED PROGRESS ON
MANUFACTURING
AND IND-ENABLING ACTIVITIES TO ADVANCE ATI-1701 INTO CLINIC
Source text for Eikon: ID:nBwbPQ2TRa
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez